Zeta CD25 Antibody. Zeta’s recombinant mouse antibody recognizes CD25, also known as the Interleukin-2 receptor alpha chain (IL-2Rα), a protein found on the surface of certain immune cells. CD25 plays a crucial role in the immune system by modulating the activity and function of T cells. CD25 antibody expression is a reliable diagnostic tool for distinguishing neoplastic mast cell aggregates from reactive proliferations. CD25 is overexpressed in some hematologic malignancies, such as adult T-cell leukemia/lymphoma (ATLL) and certain types of Hodgkin lymphoma, making it a potential target for therapeutic interventions.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.